Pseudophakic cystoid macular edema: update 2016
Open Access
- 1 September 2016
- journal article
- review article
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. ume 11, 1221-1229
Abstract
Pseudophakic cystoid macular edema: update 2016 Andrzej Grzybowski,1,2 Bartosz L Sikorski,3 Francisco J Ascaso,4,5 Valentín Huerva6,7 1Department of Ophthalmology, University of Warmia and Mazury, Olsztyn, Poland; 2Department of Ophthalmology, Poznan City Hospital, Poznan, Poland; 3Department of Ophthalmology, Nicolaus Copernicus University, Bydgoszcz, Poland; 4Department of Ophthalmology, Hospital Clínico Universitario “Lozano Blesa”, Zaragoza, Spain; 5Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain; 6Department of Ophthalmology, Universitary Hospital Arnau de Vilanova, Lleida, Spain; 7IRB Lleida, Lleida, Spain Pseudophakic cystoid macular edema (PCME) is the most common complication of cataract surgery, leading in some cases to a decrease in vision. Although the pathogenesis of PCME is not completely understood, the contribution of postsurgical inflammation is generally accepted. Consequently, anti-inflammatory medicines, including steroids and nonsteroidal anti-inflammatory drugs, have been postulated as having a role in both the prophylaxis and treatment of PCME. However, the lack of a uniformly accepted PCME definition, conflicting data on some risk factors, and the scarcity of studies comparing the role of nonsteroidal anti-inflammatory drugs to steroids in PCME prevention make the problem of PCME one of the puzzles of ophthalmology. This paper presents an updated review on the pathogenesis, risk factors, and use of anti-inflammatory drugs in PCME that reflect current research and practice. Keywords: Pseudophakic cystoid macular edema, cataract surgery, cataract surgery complications, retina, post-operative complicationsKeywords
This publication has 62 references indexed in Scilit:
- Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised studyBritish Journal of Ophthalmology, 2014
- Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathyClinical Ophthalmology, 2012
- Pseudophakic Cystoid Macular EdemaInternational Ophthalmology Clinics, 2010
- Macular thickness after uneventful cataract surgery determined by optical coherence tomographyGraefe's Archive for Clinical and Experimental Ophthalmology, 2007
- Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: Pharmacokinetic-response curveJournal of Cataract & Refractive Surgery, 2006
- Cystoid macular oedema and changes in retinal thickness after phacoemulsification with optical coherence tomographyEye, 2005
- Comparison of Diclofenac and Fluorometholone in Preventing Cystoid Macular Edema After Small Incision Cataract Surgery A Multicentered Prospective TrialJapanese Journal of Ophthalmology, 2000
- Pars Plana Vitrectomy for Chronic Pseudophakic Cystoid Macular EdemaAmerican Journal of Ophthalmology, 1995
- Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edemaJournal of Cataract & Refractive Surgery, 1995
- Cystoid macular edema: the apparent role of mechanical factors.1989